BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14594999)

  • 1. Stimulation of cardiac cardiolipin biosynthesis by PPARalpha activation.
    Jiang YJ; Lu B; Xu FY; Gartshore J; Taylor WA; Halayko AJ; Gonzalez FJ; Takasaki J; Choy PC; Hatch GM
    J Lipid Res; 2004 Feb; 45(2):244-52. PubMed ID: 14594999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Acetylsphingosine stimulates phosphatidylglycerolphosphate synthase activity in H9c2 cardiac cells.
    Xu FY; Kelly SL; Hatch GM
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):483-90. PubMed ID: 9895291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure.
    Saini-Chohan HK; Holmes MG; Chicco AJ; Taylor WA; Moore RL; McCune SA; Hickson-Bick DL; Hatch GM; Sparagna GC
    J Lipid Res; 2009 Aug; 50(8):1600-8. PubMed ID: 19001357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of the phospholipase C-mediated attenuation of cardiolipin biosynthesis in H9c2 cardiac myoblast cells.
    Xu FY; Kelly SL; Taylor WA; Hatch GM
    Mol Cell Biochem; 1998 Nov; 188(1-2):217-23. PubMed ID: 9823027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial CDP-diacylglycerol synthase activity is due to the peripheral protein, TAMM41 and not due to the integral membrane protein, CDP-diacylglycerol synthase 1.
    Blunsom NJ; Gomez-Espinosa E; Ashlin TG; Cockcroft S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):284-298. PubMed ID: 29253589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine inhibits cardiolipin biosynthesis in H9c2 cardiac myoblast cells.
    Xu FY; Taylor WA; Hatch GM
    Arch Biochem Biophys; 1998 Jan; 349(2):341-8. PubMed ID: 9448723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptors (PPAR) and the mitochondrial aldehyde dehydrogenase (ALDH2) promoter in vitro and in vivo.
    Crabb DW; Pinaire J; Chou WY; Sissom S; Peters JM; Harris RA; Stewart M
    Alcohol Clin Exp Res; 2001 Jul; 25(7):945-52. PubMed ID: 11505017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver.
    Akbiyik F; Cinar K; Demirpence E; Ozsullu T; Tunca R; Haziroglu R; Yurdaydin C; Uzunalimoglu O; Bozkaya H
    Eur J Clin Invest; 2004 Jun; 34(6):429-35. PubMed ID: 15200495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of chloroquine on cardiolipin biosynthesis in hepatocytes and H9c2 cardiac cells.
    Ross TK; Xu FY; Taylor WA; Hatch GM
    Mol Cell Biochem; 2000 Apr; 207(1-2):115-22. PubMed ID: 10888236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of the increase in cardiolipin biosynthesis and resynthesis in hepatocytes during rat liver regeneration.
    Webster J; Jiang JY; Lu B; Xu FY; Taylor WA; Mymin M; Zhang M; Minuk GY; Hatch GM
    Biochem J; 2005 Feb; 386(Pt 1):137-43. PubMed ID: 15458384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cytosolic phospholipase A(2) by PPAR activators in human preadipocytes.
    Jiang YJ; Hatch GM; Mymin D; Dembinski T; Kroeger EA; Choy PC
    J Lipid Res; 2001 May; 42(5):716-24. PubMed ID: 11352978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha-null mice lack resistance to acetaminophen hepatotoxicity following clofibrate exposure.
    Chen C; Hennig GE; Whiteley HE; Corton JC; Manautou JE
    Toxicol Sci; 2000 Oct; 57(2):338-44. PubMed ID: 11006363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis.
    Danos M; Taylor WA; Hatch GM
    Biochem Cell Biol; 2008 Feb; 86(1):11-20. PubMed ID: 18364741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues.
    Amsaguine-Safir S; Bianchi A; Collet P; Huin-Schohn C; Jeanvoine A; Bécuwe P; Krémarik-Bouillaud P; Domenjoud L; Keller JM; Schohn H; Dauça M
    Microsc Res Tech; 2003 Jun; 61(2):185-90. PubMed ID: 12740825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription.
    Pan DA; Mater MK; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
    J Lipid Res; 2000 May; 41(5):742-51. PubMed ID: 10787435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231.
    Suchanek KM; May FJ; Robinson JA; Lee WJ; Holman NA; Monteith GR; Roberts-Thomson SJ
    Mol Carcinog; 2002 Aug; 34(4):165-71. PubMed ID: 12203367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart.
    Taylor WA; Xu FY; Ma BJ; Mutter TC; Dolinsky VW; Hatch GM
    BMC Biochem; 2002 May; 3():9. PubMed ID: 12019031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cardiolipin biosynthesis in H9c2 cardiac myoblasts by cytidine 5'-triphosphate.
    Hatch GM; McClarty G
    J Biol Chem; 1996 Oct; 271(42):25810-6. PubMed ID: 8824210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamics of cardiolipin synthesis post-mitochondrial fusion.
    Xu FY; McBride H; Acehan D; Vaz FM; Houtkooper RH; Lee RM; Mowat MA; Hatch GM
    Biochim Biophys Acta; 2010 Aug; 1798(8):1577-85. PubMed ID: 20434430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
    Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.